Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis

BackgroundWhile Transcatheter Aortic Valve Replacement (TAVR) is now a standard treatment for severe aortic stenosis, its use in patients with quadricuspid aortic valves (QAV) presents unique challenges. This review analyzes current evidence to guide clinicians in managing aortic stenosis in this co...

Full description

Saved in:
Bibliographic Details
Main Authors: Mostafa A. Khalifa, Hashim Talib Hashim, Aya Ahmed Shimal, Fathima Raahima Riyas Mohamed, Srinithi Ragunathan, Ahmed Sermed Al Sakini, Mohamed H. Elbadawi, Mohammed Rushdhi Irfan, Ibrahim Moqbel, Marwah Mohammed Almualed, Mohammedbaqer Al-Ghuraibawi, Batool S. Al-Aboudi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1572251/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849694139329806336
author Mostafa A. Khalifa
Hashim Talib Hashim
Aya Ahmed Shimal
Fathima Raahima Riyas Mohamed
Srinithi Ragunathan
Ahmed Sermed Al Sakini
Mohamed H. Elbadawi
Mohammed Rushdhi Irfan
Ibrahim Moqbel
Marwah Mohammed Almualed
Mohammedbaqer Al-Ghuraibawi
Batool S. Al-Aboudi
author_facet Mostafa A. Khalifa
Hashim Talib Hashim
Aya Ahmed Shimal
Fathima Raahima Riyas Mohamed
Srinithi Ragunathan
Ahmed Sermed Al Sakini
Mohamed H. Elbadawi
Mohammed Rushdhi Irfan
Ibrahim Moqbel
Marwah Mohammed Almualed
Mohammedbaqer Al-Ghuraibawi
Batool S. Al-Aboudi
author_sort Mostafa A. Khalifa
collection DOAJ
description BackgroundWhile Transcatheter Aortic Valve Replacement (TAVR) is now a standard treatment for severe aortic stenosis, its use in patients with quadricuspid aortic valves (QAV) presents unique challenges. This review analyzes current evidence to guide clinicians in managing aortic stenosis in this complex valve morphology.MethodFollowing PRISMA guidelines, a comprehensive literature search was conducted across multiple databases up to August 15, 2024. A random-effects model was used for meta-analysis, focusing on 30-day mortality and procedural success, with secondary outcomes including paravalvular leak incidence, pacemaker insertion, hemodynamic changes, and NYHA functional class improvement.ResultsA total of 11 case reports/series were analyzed, involving 17 adult patients with QAV. Participants had a mean age of 73.80 ± 5.07 years. The mean left ventricular ejection fraction was 41.6%, and the mean annulus area was 595.5 mm2. Most patients (64.7%) underwent transfemoral procedures, with nearly 70% receiving a J-valve or Edwards SAPIEN 3 device. All procedures were largely successful, though 29.4% experienced leakage or regurgitation. Aortic pre-dilation was done in 41.2% of cases. The mean procedural duration was 102 min, with a fluoroscopic duration of 15 min. No patients experienced aortic post-dilation, and one (5.8%) had an atrioventricular block within 30 days post-procedure.ConclusionTAVR is an effective and growing treatment for high-risk patients with aortic valve disease, including those with QAV. While it has high success rates and challenges (i.e., post-operatively). Future studies should focus on long-term valve durability.
format Article
id doaj-art-6ba0f27d0e474f64b8562391776fe4c0
institution DOAJ
issn 2297-055X
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-6ba0f27d0e474f64b8562391776fe4c02025-08-20T03:20:11ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-05-011210.3389/fcvm.2025.15722511572251Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysisMostafa A. Khalifa0Hashim Talib Hashim1Aya Ahmed Shimal2Fathima Raahima Riyas Mohamed3Srinithi Ragunathan4Ahmed Sermed Al Sakini5Mohamed H. Elbadawi6Mohammed Rushdhi Irfan7Ibrahim Moqbel8Marwah Mohammed Almualed9Mohammedbaqer Al-Ghuraibawi10Batool S. Al-Aboudi11Faculty of Medicine, Cairo University, Cairo, EgyptCollege of Medicine, University of Warith Al-Anbiyaa, Karbala, IraqCollege of Medicine, University of Baghdad, Baghdad, IraqCollege of Medicine, Alfaisal University, Riyadh, Saudi ArabiaPanimalar Medical College and Research Institute, Chennai, IndiaCollege of Medicine, University of Baghdad, Baghdad, IraqFaculty of Medicine, University of Khartoum, Khartoum, SudanCollege of Medicine, Alfaisal University, Riyadh, Saudi ArabiaFaculty of Medicine, Cairo University, Cairo, EgyptCollege of Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaCollege of Medicine, University of Warith Al-Anbiyaa, Karbala, IraqFaculty of Medicine, University of Kufa, Najaf, IraqBackgroundWhile Transcatheter Aortic Valve Replacement (TAVR) is now a standard treatment for severe aortic stenosis, its use in patients with quadricuspid aortic valves (QAV) presents unique challenges. This review analyzes current evidence to guide clinicians in managing aortic stenosis in this complex valve morphology.MethodFollowing PRISMA guidelines, a comprehensive literature search was conducted across multiple databases up to August 15, 2024. A random-effects model was used for meta-analysis, focusing on 30-day mortality and procedural success, with secondary outcomes including paravalvular leak incidence, pacemaker insertion, hemodynamic changes, and NYHA functional class improvement.ResultsA total of 11 case reports/series were analyzed, involving 17 adult patients with QAV. Participants had a mean age of 73.80 ± 5.07 years. The mean left ventricular ejection fraction was 41.6%, and the mean annulus area was 595.5 mm2. Most patients (64.7%) underwent transfemoral procedures, with nearly 70% receiving a J-valve or Edwards SAPIEN 3 device. All procedures were largely successful, though 29.4% experienced leakage or regurgitation. Aortic pre-dilation was done in 41.2% of cases. The mean procedural duration was 102 min, with a fluoroscopic duration of 15 min. No patients experienced aortic post-dilation, and one (5.8%) had an atrioventricular block within 30 days post-procedure.ConclusionTAVR is an effective and growing treatment for high-risk patients with aortic valve disease, including those with QAV. While it has high success rates and challenges (i.e., post-operatively). Future studies should focus on long-term valve durability.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1572251/fulltranscatheter aortic valve replacementquadricuspid aortic valvesaortic stenosisprocedural successQVA
spellingShingle Mostafa A. Khalifa
Hashim Talib Hashim
Aya Ahmed Shimal
Fathima Raahima Riyas Mohamed
Srinithi Ragunathan
Ahmed Sermed Al Sakini
Mohamed H. Elbadawi
Mohammed Rushdhi Irfan
Ibrahim Moqbel
Marwah Mohammed Almualed
Mohammedbaqer Al-Ghuraibawi
Batool S. Al-Aboudi
Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis
Frontiers in Cardiovascular Medicine
transcatheter aortic valve replacement
quadricuspid aortic valves
aortic stenosis
procedural success
QVA
title Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis
title_full Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis
title_fullStr Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis
title_full_unstemmed Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis
title_short Transcatheter aortic valve replacement in quadricuspid aortic valve: a systematic review and meta-analysis
title_sort transcatheter aortic valve replacement in quadricuspid aortic valve a systematic review and meta analysis
topic transcatheter aortic valve replacement
quadricuspid aortic valves
aortic stenosis
procedural success
QVA
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1572251/full
work_keys_str_mv AT mostafaakhalifa transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT hashimtalibhashim transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT ayaahmedshimal transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT fathimaraahimariyasmohamed transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT srinithiragunathan transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT ahmedsermedalsakini transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT mohamedhelbadawi transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT mohammedrushdhiirfan transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT ibrahimmoqbel transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT marwahmohammedalmualed transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT mohammedbaqeralghuraibawi transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis
AT batoolsalaboudi transcatheteraorticvalvereplacementinquadricuspidaorticvalveasystematicreviewandmetaanalysis